Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

Bone Marrow Transplantation - Tập 37 Số 5 - Trang 439-449 - 2006
Per Ljungman1, Álvaro Urbano-Ispízua2, Marina Cavazzana3, T. Demirer4, Giorgio Dini5, Hermann Einsele6, Aloïs Gratwohl7, J. Alejandro Madrigal8, Dietger Niederwieser9, Jakob Passweg10, Vanderson Rocha11, Riccardo Saccardi12, H. Schouten13, Norbert Schmitz14, Gèrard Socié11, Anna Sureda15, Jane F. Apperley16
1Department of Hematology, Karolinska University Hospital, Stockholm, Sweden
2Hospital Clinic, Barcelona, Spain
3Department of Biotherapy, Hopital Necker, Paris, France
4Department of Hematology/Oncology, Ibn-i Sina Hospital, Ankara University Medical School, Ankara, Turkey
5Department of Paediatric Haematology and Oncology, IRCCS ‘G.Gaslini’, Genoa, Italy
6Department of Hematology and Oncology, University of Würzburg, Würzburg, Germany
7Hematology division, University Hospital, Basel, Switzerland
8Anthony Nolan Bone Marrow Trust, Royal Free Hospital, London, UK
9Department of Hematology and Oncology, University of Leipzig, Leipzig, Germany
10Hematology Division, Geneva University Hospital, Geneva, Switzerland
11Department of Hematology, BMT Unit, Hopital St Louis, Paris, France
12Department Hematology, Careggi Hospital & University of Florence, Florence, Italy
13Department of Internal Medicine, section of Hematology-Oncology, Maastricht, The Netherlands
14Department of Hematology, AK St. Georg, Hamburg, Germany
15Clinical Hematology Division, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
16Department of Haematology, Imperial College School of Medicine, Hammersmith Hospital, London, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Schmitz N, Gratwohl A, Goldman JM . Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1996 and proposals for an operational classification. Bone Marrow Transplant 1996; 17: 471–477.

Goldman JM, Schmitz N, Niethammer D, Gratwohl A . Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Bone Marrow Transplant 1998; 21: 1–7.

Gratwohl A, Hermans J, Baldomero H, Tichelli A, Goldman JM, Gahrton G . Indications for haemopoietic precursor cell transplants in Europe. Br J Haematol 1996; 92: 35–43.

Urbano-Ispizua A, Schmitz N, de Witte T, Frassoni F, Rosti G, Schrezenmeier H et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 2002; 29: 639–646.

Eapen M, Horowitz MM, Klein JP, Champlin RE, Loberiza Jr FR, Ringden O et al. Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. J Clin Oncol 2004; 22: 4872–4880.

Link H, Schmitz N, Gratwohl A, Goldman JM . Standards for specialist units undertaking blood and marrow stem cell transplants – recommendations from the EBMT. Bone Marrow Transplant 1995; 16: 733–763.

Joint Accreditation Committee. EBMT-EuroISHAGE (JACIE) Accreditation Manual (www.jacie.org).

Thông tin
Thông tin xuất bản

Bone Marrow Transplantation

Tập 37 Số 5

439-449

Thông tin tác giả